IP Library Granted Patent US 7,981,626
Granted Patent B2
US 7,981,626 · App. 12/460,724 · Granted Jul 19, 2011

Method of detecting endometriosis in human subjects using SEQ ID No. 9 or an epitope thereof

Assignee: Siemens Healthcare Diagnostics Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,981,626
App. No.
12/460,724
Granted
Jul 19, 2011
Kind
B2
Abstract

A method for diagnosing endometriosis in a human subject comprising the steps of detecting a test amount of an antibody that specifically binds to SEQ ID NO:9 polypeptide or a truncated peptide comprising an epitope of SEQ ID NO: 9, in a sample from the subject; and comparing the test amount with a normal range of the antibody in a control sample from a subject who does not suffer from endometriosis, whereby a test amount above the normal range provides a positive indication in the diagnosis of endometriosis.

Claims (9)

1. A method for diagnosing endometriosis in a human subject comprising the steps of:

(a) detecting a test amount of an antibody that specifically binds to SEQ ID NO:9 polypeptide or a truncated peptide comprising an epitope of SEQ ID NO: 9, in a sample from the subject; and

(b) comparing the test amount with a normal range of the antibody in a control sample from a subject who does not suffer from endometriosis, whereby a test amount above the normal range provides a positive indication in the diagnosis of endometriosis.

2. The method of claim 1 , wherein the sample comprises blood serum.

3. The method of claim 1 or 2 , wherein the step of detecting comprises capturing the antibody from the sample with an immobilized peptide where said peptide is SEQ ID NO: 9 or a peptide comprising an epitope of SEQ ID NO: 9 and detecting captured antibody.

4. The method of claim 1 wherein said polypeptide has amino acid sequences identical to SEQ ID NO: 9.

5. The method of claim 1 wherein said peptide is a truncated peptide comprising an epitope of SEQ ID NO: 9.

6. The method of claim 1 wherein said SEQ ID NO: 9 polypeptide is produced by recombinant means.

7. The method of claim 1 wherein said truncated peptide of SEQ ID NO: 9 is produced by recombinant means.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 10, 2011
From: EL SHAMI, A. SAID; CAMPBELL, BRUCE; SUSTARSIC, DENNIS; SAHAKIAN, NIVER
To: DIAGNOSTIC PRODUCTS CORPORATION
Reel/Frame 026250/0017 →
CHANGE OF NAME Recorded May 10, 2011
From: DIAGNOSTIC PRODUCTS CORPORATION
To: SIEMENS MEDICAL SOLUTIONS DIAGNOSTICS
Reel/Frame 026250/0028 →
CHANGE OF NAME Recorded May 10, 2011
From: SIEMENS MEDICAL SOLUTIONS DIAGNOSTICS
To: SIEMENS HEALTHCARE DIAGNOSTICS INC.
Reel/Frame 026250/0125 →
Continuity (3)
Division 11593693 · Nov 6, 2006
Division 10887540 · Jul 7, 2004
Related Publication 20100330696A1 · Dec 30, 2010